Leo Wealth LLC Buys 481 Shares of Kenvue Inc. (NYSE:KVUE)

Leo Wealth LLC raised its stake in shares of Kenvue Inc. (NYSE:KVUE) by 0.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 151,611 shares of the company’s stock after buying an additional 481 shares during the quarter. Leo Wealth LLC’s holdings in Kenvue were worth $3,507,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Mather Group LLC. bought a new position in shares of Kenvue in the first quarter worth $28,000. Park Avenue Securities LLC increased its stake in Kenvue by 11.1% in the 1st quarter. Park Avenue Securities LLC now owns 36,322 shares of the company’s stock worth $779,000 after acquiring an additional 3,625 shares during the last quarter. Global Assets Advisory LLC purchased a new stake in shares of Kenvue in the 1st quarter valued at about $654,000. Riverview Trust Co bought a new stake in shares of Kenvue during the 1st quarter valued at about $33,000. Finally, Columbus Macro LLC grew its holdings in shares of Kenvue by 26.0% during the first quarter. Columbus Macro LLC now owns 76,727 shares of the company’s stock worth $1,647,000 after purchasing an additional 15,844 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on KVUE shares. UBS Group raised their target price on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Citigroup lowered their price objective on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. Bank of America lifted their price objective on shares of Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Tuesday. Piper Sandler lifted their price objective on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a report on Monday, September 23rd. Finally, Jefferies Financial Group began coverage on shares of Kenvue in a report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price objective for the company. One analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus target price of $22.64.

Kenvue Trading Up 0.5 %

Kenvue stock traded up $0.11 during mid-day trading on Tuesday, hitting $23.03. The company’s stock had a trading volume of 13,232,893 shares, compared to its average volume of 18,201,803. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.99 and a quick ratio of 0.68. The stock has a market cap of $44.10 billion, a price-to-earnings ratio of 29.31, a price-to-earnings-growth ratio of 2.76 and a beta of 1.40. The business has a 50 day moving average price of $22.30 and a 200-day moving average price of $20.22. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $23.55.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.04. The business had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The firm’s revenue for the quarter was down .3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.32 earnings per share. As a group, analysts forecast that Kenvue Inc. will post 1.08 EPS for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.56%. The ex-dividend date is Wednesday, November 13th. Kenvue’s payout ratio is 105.13%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.